Ganirelix acetate and Dyspnea exacerbated - a phase IV clinical study of FDA data
We study 1,388 people who have side effects when taking Ganirelix acetate. Dyspnea exacerbated is found, especially among people who are female, 30-39 old, have been taking the drug for < 1 month, also take Menopur and have Infertility.
The phase IV clinical study analyzes which people take Ganirelix acetate and have Dyspnea exacerbated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,388 people reported to have side effects when taking Ganirelix acetate.
Among them, 28 people (2.02%) have Dyspnea exacerbated.
What is Ganirelix acetate?
Ganirelix acetate has active ingredients of ganirelix acetate. Currently, eHealthMe is studying from 1,390 Ganirelix acetate users.
What is Dyspnea exacerbated?
Dyspnea exacerbated is found to be associated with 3,114 drugs and 1,416 conditions by eHealthMe. Currently, we are studying 2,061 people who have Dyspnea exacerbated.
Number of Ganirelix acetate and Dyspnea exacerbated reports submitted per year:
Time on Ganirelix acetate when people have Dyspnea exacerbated *:
Gender of people who have Dyspnea exacerbated when taking Ganirelix acetate*:
Age of people who have Dyspnea exacerbated when taking Ganirelix acetate *:
Common drugs people take besides Ganirelix acetate *:
Common side effects people have besides Dyspnea exacerbated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Ganirelix acetate and have Dyspnea exacerbated?Check whether Dyspnea exacerbated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Ganirelix acetate side effects by duration, gender and age:
- Ganirelix acetate side effects (1,390 reports)
Dyspnea exacerbated treatments and more:
- Dyspnea exacerbated (2,061 reports)
Common drugs associated with Dyspnea exacerbated:
- Prednisone: 46,055 reports
- Aspirin: 33,363 reports
- Spiriva: 27,866 reports
- Symbicort: 22,890 reports
- Furosemide: 21,053 reports
- Albuterol: 20,928 reports
- Omeprazole: 19,370 reports
- Amlodipine: 18,329 reports
- Methotrexate: 17,130 reports
- Lasix: 16,882 reports
All the drugs that are associated with Dyspnea exacerbated:
- Dyspnea exacerbated (3,114 drugs)
Common conditions associated with Dyspnea exacerbated:
- Asthma: 40,098 reports
- Primary pulmonary hypertension: 34,524 reports
- High blood pressure: 26,605 reports
- Rheumatoid arthritis: 25,083 reports
- Chronic obstructive pulmonary disease: 24,688 reports
- Pain: 15,402 reports
- Multiple sclerosis: 14,228 reports
All the conditions that are associated with Dyspnea exacerbated:
- Dyspnea exacerbated (1,416 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ganirelix acetate (the active ingredients of Ganirelix acetate) and Ganirelix acetate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tranexamic Acid and Norcuron drug interaction - 6 seconds ago
- Provera and Ery-Tab drug interaction - 6 seconds ago
- Nucala and Dulera drug interaction - 9 seconds ago
- Biaxin and Herpes Zoster - 12 seconds ago
- Ultram and Micafungin drug interaction - 14 seconds ago
- Ozempic and Acetylsalicylate Lysine drug interaction - 26 seconds ago
- Vancomycin and Garamycin drug interaction - 34 seconds ago
- Diphen and Bone Marrow Failure - 36 seconds ago
- Valtrex and Xylometazoline Hydrochloride drug interaction - 36 seconds ago
- Moxifloxacin Hydrochloride and Glimepiride drug interaction - 37 seconds ago